Trials / Completed
CompletedNCT02569775
Outcomes of Stem Cells for Cerebral Palsy
Outcomes of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy: A Self-Controlled Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Vinmec Healthcare System · Academic / Other
- Sex
- All
- Age
- 1 Year – 15 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the safety and effectiveness of autologous bone marrow mononuclear stem cells in patients with cerebral palsy.
Detailed description
The aim of this study is to assess the safety and effectiveness of autologous bone marrow mononuclear stem cells in 40 patients with cerebral palsy at Vinmec International Hospital, Hanoi, Vietnam.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous Bone Marrow Mononuclear Cells | Transplantation of Autologous Bone Marrow Mononuclear Cells |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2015-10-07
- Last updated
- 2015-10-16
Locations
1 site across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT02569775. Inclusion in this directory is not an endorsement.